Is micafungin more active against Candida albicans biofilms with high metabolic activity?
Our study suggests that the metabolic activity of biofilm may have a role in future evaluations of micafungin for the eradication of C. albicans biofilms (e.g. the lock therapy approach).
PTX confers protection against future major cardiovascular events and death in select CRF patients with severe refractory SHPT.